Original Articles

How Much Digital Rectal Examination is Valuable for the Decision of Biopsy in Patients with PSA ≤4 ng/ml?
  • Özgü Aydoğdu
  • İbrahim Halil Bozkurt
  • Tarık Yonguç
  • Tansu Değirmenci
  • Salih Polat
  • Bülent Günlüsoy
  • İbrahim Küçüktürkmen
  • Yasin Ceylan
  • Süleyman Minareci
Bull Urooncol 2015; 14: 1-4 DOI: 10.4274/uob.253
Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?
  • Soner Çoban
  • Muhammet Güzelsoy
  • Ali Rıza Türkoğlu
  • Ünal Kurtoğlu
  • Dursun Ünal
  • Noyan Can Akdur
  • Sedat Öner
  • Murat Demirbaş
Bull Urooncol 2015; 14: 83-87 DOI: 10.4274/uob.268

Review

PSA: past, today and tomorrow
  • Levent Mert Günay
  • Sertaç Yazıcı
  • Haluk Özen
Bull Urooncol 2011; 10: 5-10
  • Çagatay Gögüs
Bull Urooncol 2006; 5: 6-11
  • Sinan Sözen
  • Serhat Gürocak
  • Cenk Acar
Bull Urooncol 2004; 3: 13-18
Yükselen PSA durumunda kullanılan görüntüleme yöntemleri bize ne ölçüde yardımcı oluyor?
  • Reşit Tokuç
  • Asıf Yıldırım
Bull Urooncol 2010; 9: 31-36
Tekrarlayan prostat biyopsilerinde ideal bir biyopsi şeması var mıdır? PCA3 PSA kadar faydalı mıdır?
  • Kaya Horasanlı
  • Mustafa Aydın
Bull Urooncol 2010; 9: 47-52
Algorithmic approach to rising PSA after curative prostate cancer treatment
  • Levent Mert Günay
  • Şevket Tolga Tombul
  • Bülent Akdoğan
Bull Urooncol 2011; 10: 51-55
What is the best cutoff value of PSA in detection of prostate cancer
  • Hakan Gemalmaz
Bull Urooncol 2012; 11: 92-95
NON-PSA biomarkers for prostate cancer
  • Yarkın Kamil Yakupoğlu
  • Yakup Bostancı
  • Ender Özden
Bull Urooncol 2012; 11: 96-102
Evaluation of the Current Situation Tissue and Serum Biomarkers in Prostate Cancer
  • Enis Kervancıoğlu
  • Murat Koşan
Bull Urooncol 2015; 14: 102-107 DOI: 10.4274/uob.320
Repeat prostate biopsy: who, when, how?
  • Hayrettin Şahin
Bull Urooncol 2012; 11: 103-107
How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?
  • İlker Çelen
  • Murat Lekili
Bull Urooncol 2013; 12: 127-131
Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?
  • Gül Alço
  • Sefik İğdem
Bull Urooncol 2015; 14: 161-164 DOI: 10.4274/uob.387

Article - Comment

  • Emre Tüzel
Bull Urooncol 2006; 5: 17-18
  • Bülent Akduman
Bull Urooncol 2005; 4: 23-24
Time to prostate spesific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality
  • Mustafa Kaplan
Bull Urooncol 2006; 5: 28-30

Original Article

Relationship Between AMACR Staining Density of Radical Prostatectomy Specimen and Biochemical Recurrence in Patients with Pathological Stage T2a-b
  • Murat Kars
  • Ersin Gökmen
  • Oktay Özman
  • Serkan Gönültaş
  • Burak Arslan
Bull Urooncol 2020; 19: 38-41 DOI: 10.4274/uob.galenos.2019.1381
What is the Prostate Specific Antigen Cut-off Value to Detect Metastases in Ga-68 Prostate Specific Membrane Antigen Ligand Positron Emission Tomography/ Computer Tomography Imaging for Intermediate and High-risk Prostate Cancer?
  • Burak Köprü
  • Turgay Ebiloğlu
  • Engin Kaya
  • Engin Alagöz
  • Murat Zor
  • Mustafa Özdeş Emer
  • Mesut Gürdal
  • Selahattin Bedir
  • Nuri Arslan
Bull Urooncol 2020; 19: 151-156 DOI: 10.4274/uob.galenos.2020.1499

About Journal

Forms

Useful Links

Applications